These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8643186)

  • 1. Anticoagulation for heparin-induced thrombocytopenia with spontaneous platelet aggregation in a patient requiring haemodialysis.
    Koide M; Yamamoto S; Matsuo M; Suzuki S; Arima N; Matsuo T
    Nephrol Dial Transplant; 1995 Nov; 10(11):2137-40. PubMed ID: 8643186
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
    Matsuo T; Matsuo M; Ouga-Maruyama S
    Thromb Haemost; 2001 Oct; 86(4):1115-6. PubMed ID: 11686333
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between platelet factor 4/heparin complexes ELISA and platelet aggregation test in heparin-induced thrombocytopenia.
    Nguyên P; Droullé C; Potron G
    Thromb Haemost; 1995 Aug; 74(2):804-5. PubMed ID: 8585032
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndrome.
    Bounameaux C; Boehlen F; Membré A; Genné D; Pouplard C; Regnault V; de Moerloose P
    Eur J Haematol; 2007 Dec; 79(6):550-3. PubMed ID: 17961179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
    Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
    Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and features of heparin-induced thrombocytopenia (HIT) in burn patients: a retrospective study.
    Hejl CG; Leclerc T; Bargues L; Samson T; Foissaud V
    Thromb Haemost; 2008 May; 99(5):974-6. PubMed ID: 18449436
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia syndrome and thrombosis in patients undergoing periodic haemodialysis].
    Gregorini G; Bellandi D; Martini G; Volpi R
    G Ital Nefrol; 2002; 19(6):672-92. PubMed ID: 12508172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia (HIT) in patients on hemodialysis: an update.
    Szromba C
    Nephrol Nurs J; 2010; 37(2):185-7. PubMed ID: 20462079
    [No Abstract]   [Full Text] [Related]  

  • 12. What are the options for anticoagulation needs in dialysis for patients with heparin-induced thrombocytopenia?
    Davenport A
    Semin Dial; 2011; 24(4):382-5. PubMed ID: 21851394
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of heparin-induced thrombocytopenia in a patient on hemodialysis complicated with thrombosis in the extracorporeal circuit].
    César JM; Candela A; Tenorio MT; Chinea A; Sáiz R; Liaño F
    Nefrologia; 2008; 28(4):462-3. PubMed ID: 18662159
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 15. Review: anticoagulation for haemodialysis.
    Suranyi M; Chow JS
    Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
    Matsuo T; Wanaka K
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):459-64. PubMed ID: 18160571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
    Charif R; Davenport A
    Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative antiaggregant strategy for off-pump coronary artery bypass grafting in a patient with heparin-induced thrombocytopenia.
    Zanobini M; Barili F; Alamanni F; Dainese L; Stringi V; Cappai A; Dell'orto M; Porqueddu M; Roberto M; Kassem S; Pompilio G; Biglioli P
    Heart Surg Forum; 2008; 11(1):E54-5. PubMed ID: 18270143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
    Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.